Showing results (1-10 of 92) with videos related to
Sort By:
Pageof 10
The New Zealand Medical Journal|September 22, 2022
Helicobacter pylori in New Zealand: current diagnostic trends and related costsJan Kubovy, Murray L BarclayRheumatology (Oxford, England)|December 23, 2017
How to prevent allopurinol hypersensitivity reactions?Lisa K Stamp, Murray L BarclayPharmacogenomics|June 13, 2015
Update on thiopurine pharmacogenetics in inflammatory bowel diseaseRebecca L Roberts, Murray L BarclayJournal of Gastroenterology and Hepatology|June 30, 2012
Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's diseaseRebecca L Roberts, Murray L BarclayCurrent Opinion in Pharmacology|October 29, 2020
Cost-effectiveness of therapeutic drug monitoring in inflammatory bowel diseaseRichard P McNeill, Murray L BarclayJournal of Gastroenterology and Hepatology|July 29, 2005
Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel diseaseRichard B Gearry, Murray L BarclayInternal Medicine Journal|December 23, 2020
A 1 g dose of intravenous iron is sufficient to treat iron deficiency anaemiaSyarihan Karim, Jennifer M Butler, Murray L BarclayInflammatory Bowel Diseases|March 10, 2018
Late-onset Rise of 6-MMP Metabolites in IBD Patients on Azathioprine or MercaptopurineErik Munnig-Schmidt, Mei Zhang, Chris J Mulder, et al.Antimicrobial Agents and Chemotherapy|November 14, 2012
A simple high-performance liquid chromatography method for simultaneous determination of three triazole antifungals in human plasmaMei Zhang, Grant A Moore, Murray L Barclay, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 4, 2009
Determination of perhexiline and its metabolite hydroxyperhexiline in human plasma by liquid chromatography/tandem mass spectrometryMei Zhang, Grant A Moore, Murray L Barclay, et al.Pageof 10